fax: (206) 667-2537
Version of Record online: 19 DEC 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 55, Issue 2, pages 483–490, February 2012
How to Cite
Shang, S., Plymoth, A., Ge, S., Feng, Z., Rosen, H. R., Sangrajrang, S., Hainaut, P., Marrero, J. A. and Beretta, L. (2012), Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology, 55: 483–490. doi: 10.1002/hep.24703
Potential conflict of interest: Nothing to report.
This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the U.S. National Institutes of Health (NIH) (R01DK066840; to L.B.) by the National Cancer Institute of the U.S. NIH (R01CA120719; to L.B.). and by Mérieux Alliance in the context of its strategy of contributing to scientific and medical progress.
Amelie Plymoth is currently affiliated with the Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
- Issue online: 27 JAN 2012
- Version of Record online: 19 DEC 2011
- Accepted manuscript online: 27 SEP 2011 01:34PM EST
- Manuscript Accepted: 20 SEP 2011
- Manuscript Received: 15 JUN 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.